Since there are prospects for use of IL-2 and IL-4 in the treatment of autoimmune diseases or infections, the respective contribution of T cell cytokine production to the pathogenesis of autoimmune diseases is still a matter of debate (Carbo et al., 2014; Barrat and Su, 2019). This evidence concerns the gene IL4 and autoimmune disease.